[Federal Register Volume 68, Number 199 (Wednesday, October 15, 2003)]
[Notices]
[Page 59424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-25974]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration on the Boston Stock Exchange, Inc. (Able Laboratories, 
Inc., Common Stock, $.01 par value) File No. 1-11352

October 8, 2003.
    Able Laboratories, Inc., a Delaware corporation (``Issuer''), has 
filed an application with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 12(d) of the Securities Exchange 
Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) thereunder,\2\ to withdraw 
its Common Stock, $.01 par value (``Security''), from listing and 
registration on the Boston Stock Exchange, Inc, (``BSE'' or 
``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    On September 19, 2003, the Board of Directors (``Board'') of the 
Issuer approved a resolution to withdraw the Security from listing on 
the Exchange. The Board states that it made the decision to withdraw 
the Security from listing and registration on the BSE because the 
Security has been listed to trade on the Nasdaq National Market since 
February 27, 2003.
    The Issuer stated in its application that it has met the 
requirements of the BSE rules governing an issuer's voluntary 
withdrawal of a security from listing and registration. The Issuer's 
application relates solely to the Security's withdrawal from listing on 
the BSE and from registration under Section 12(b) of the Act \3\ and 
shall not affect its obligation to be registered under Section 12(g) of 
the Act.\4\
    Any interested person may, on or before October 30, 2003, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the BSE and what terms, if any, should be imposed by the Commission for 
the protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 03-25974 Filed 10-14-03; 8:45 am]
BILLING CODE 8010-01-P